FDA — authorised 21 November 2019
- Application: NDA212839
- Marketing authorisation holder: SK LIFE
- Status: supplemented
FDA authorised Maintenance on 21 November 2019
Yes. FDA authorised it on 21 November 2019; FDA has authorised it.
SK LIFE holds the US marketing authorisation.